About

About OraSure Technologies About OraSure Technologies, Inc. OraSure Technologies, Inc. transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample collection solutions. OraSure, together with its subsidiaries, DNA Genotek and Sherlock Biosciences, is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Our portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, commercial entities, and direct to consumers. We are committed to solving the world’s most complex testing challenges. Our legacy of innovation includes first-to-market rapid diagnostics for HIV, Hepatitis C, COVID-19 and Ebola, as well as oral fluid laboratory tests for detecting various drugs of abuse.